Home Cart 0 Sign in  
X

[ CAS No. 65202-50-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 65202-50-8
Chemical Structure| 65202-50-8
Chemical Structure| 65202-50-8
Structure of 65202-50-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 65202-50-8 ]

Related Doc. of [ 65202-50-8 ]

Alternatived Products of [ 65202-50-8 ]

Product Details of [ 65202-50-8 ]

CAS No. :65202-50-8 MDL No. :MFCD08694876
Formula : C6H5ClN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :FPKXYXKLOWAIOX-UHFFFAOYSA-N
M.W : 172.57 Pubchem ID :12379801
Synonyms :

Calculated chemistry of [ 65202-50-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 38.32
TPSA : 52.08 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.65
Log Po/w (XLOGP3) : -0.25
Log Po/w (WLOGP) : 0.92
Log Po/w (MLOGP) : 0.56
Log Po/w (SILICOS-IT) : 1.38
Consensus Log Po/w : 0.85

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.02
Solubility : 16.3 mg/ml ; 0.0946 mol/l
Class : Very soluble
Log S (Ali) : -0.39
Solubility : 71.0 mg/ml ; 0.412 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.34
Solubility : 0.789 mg/ml ; 0.00457 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.8

Safety of [ 65202-50-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 65202-50-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 65202-50-8 ]
  • Downstream synthetic route of [ 65202-50-8 ]

[ 65202-50-8 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 65202-50-8 ]
  • [ 66346-83-6 ]
Reference: [1] Heterocycles, 1992, vol. 34, # 2, p. 225 - 228
  • 2
  • [ 63001-30-9 ]
  • [ 65202-50-8 ]
YieldReaction ConditionsOperation in experiment
79% for 2.5 h; Reflux B.
A mixture of 6-hydroxypyridazine-3-carboxylic acid methyl ester obtained above and phosphorous oxychloride were carefully heated to reflux temperature and maintained there for 2.5 h.
The reaction mixture was then cooled and evaporated in vacuo to remove excess phosphorylchloride, and the residue was then poured into ice water.
The precipitate was collected by filtration, washed with saturated NaHCO3 and water, and dried under vacuum to yield the product as a yellow solid (4.359 g, 79percent yield).
50% With trichlorophosphate In toluene at 120℃; POCl3 (5.60g, 0.036mol) was added to a solution of Example 65A (2.8g, 0.018mol) in toluene at room temperatureand the mixture was heated to 120°C and stirred for 2 hours. The solvent was evaporated to dryness, water (20mL)was added and the mixture was extracted with ethyl acetate (15mL 3 3). The combined organic layer was washed withbrine, dried over sodium sulfate, filtered and the filtrate was evaporated. The residue was purified by column chromatographyto give the title compound (1.5g, yield 50percent). 1H NMR (CHLOROFORM-d, Bruker Avance 400 MHz) ppm 8.17(d, J=8.8 Hz, 1H), 7.68 (d, J=8.8 Hz, 1H), 4.09 (s, 3H).
Reference: [1] Patent: EP2316827, 2016, B1, . Location in patent: Paragraph 0124
[2] Patent: EP3333157, 2018, A1, . Location in patent: Paragraph 0375; 0376; 0394; 0395
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 9, p. 3814 - 3830
  • 3
  • [ 6531-04-0 ]
  • [ 65202-50-8 ]
YieldReaction ConditionsOperation in experiment
65% With methanol In dichloromethane at 0℃; for 1 h; PREPARATION 58 6-Chloro-pyridazine-3-carboxylic acid methyl ester Oxalyl chloride (1.14mL, 13.09mmol), was added dropwise to an ice-cold suspension of 6-CHLORO-PYRIDAZINE-3-CARBOXYLIC acid [(1.9g, 11.9mmol), J. Het. Chem. 29 (6), 1583-92,. 1992] in a mixture of DICHBROMETHANE (50ML) AND N, N-dimethylformamide (1 drop) and the mixture was stirred for 1 hour at room temperature. The reaction mixture was then evaporated under reduced pressure and the residue was diluted with dichloromethane (30ML) and cooled to 0°C. Methanol (485μL, 11.9mmol) was added and the mixture was stirred at 0°C for 1 hour. Sodium hydrogen carbonate solution was then added to the reaction mixture and the aqueous layer was separated and extracted with DICHLOROMETHANE (X2).. The combined organic solutions were washed with brine, - dried over-sodium sulfate and concentrated in. vacuo to afford the title compound as a white solid in 65percent yield, 1.33g. .-IHNMR (CDCL3, 400MHZ) No.: 4.09 (s, 3H),-7. 67 (d, 1H), 8.16(d, 1H). MS APCI+ m/z 173 [MH]+
Reference: [1] Patent: WO2005/28452, 2005, A1, . Location in patent: Page/Page column 84
  • 4
  • [ 63001-30-9 ]
  • [ 65202-50-8 ]
YieldReaction ConditionsOperation in experiment
79% for 2.5 h; Heating / reflux B. A mixture of 6-hydroxypyridazine-3-carboxylic acid methyl ester obtained above and phosphorous oxychloride were carefully heated to reflux and maintained there for 2.5 h. The reaction mixture was then cooled and evaporated in vacuo to remove excess phosphorylchloride, and the residue was then poured into ice water. The precipitate was collected by filtration, washed with saturated NaHCO3 and water, and dried under vacuum to yield the product as a yellow solid (4.359 g, 79percent yield).
68% at 110℃; for 5 h; A sample of S48 (333 mg, 2.16 mmol) was dissolved in POCl3 (3.2 mL) and warmed at 110 0C for 5 h. Upon disappearance of starting material, the solution was cooled to room temperature and diluted with EtOAc. The organic layer was poured onto ice and extracted. The organic layer was subsequently washed with saturated aqueous NaCl. The aqueous layer was back extracted with EtOAc and the combined organic phase was dried over Na2SO4 and filtered. The solution was evaporated and the residue was purified by flash chromatography (50percent EtOAc-hexanes) to afford the title compound as a yellowish solid (254 mg, 68percent): 1H NMR (CDCl3, 400 MHz) δ 8.17 (d, IH, J = 8.8 Hz), 7.68 (d, IH, J = 8.8 Hz), 4.08 (s, 3H); 13C NMR (CDCl3, 100 MHz) 6 159.5, 150.8, 129.8, 128.9, 53.7.
Reference: [1] Patent: WO2006/34440, 2006, A2, . Location in patent: Page/Page column 43
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 15, p. 4392 - 4403
[3] Patent: WO2010/5572, 2010, A2, . Location in patent: Page/Page column 85-86
  • 5
  • [ 5096-73-1 ]
  • [ 124-41-4 ]
  • [ 65202-50-8 ]
YieldReaction ConditionsOperation in experiment
72%
Stage #1: for 3 h; Heating / reflux
Stage #2: at 20℃;
A solution of 6-chloro-pyridazine-3-carboxylic acid (700 mg, 4.53mmol) in thionyl chloride (15 ml) was refluxed for 3 h. The reaction was cooled to ambient temperature and evaporated to dryness. Sodium methoxide (244 mg, 4.53 mmol) in [MEOH] (20 ml) was added to the residue and the solution was stirred on at room temperature (rt). [H2O] was added and the mixture was extracted three times with DCM. The combined organic phases were dried and concentrated. Flashchromatography [(SI02,] Heptane/EtOAc 1: 1) afforded 560 mg (72percent) of the title compound. [1H] NMR [(CDC13),] 5 (ppm): 4.09 (s, 3 H), 7.69 (d, 1 H), 8. 18 (d, 1 H). [LC-MS] [(M++1)] : 173 and 175 (3: 1).
Reference: [1] Patent: WO2004/14881, 2004, A2, . Location in patent: Page 149
  • 6
  • [ 67-56-1 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: WO2007/71023, 2007, A1, . Location in patent: Page/Page column 36
  • 7
  • [ 67-56-1 ]
  • [ 6531-04-0 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: WO2007/9236, 2007, A1, . Location in patent: Page/Page column 43
[2] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 1, p. 479 - 483
[3] Patent: WO2015/143653, 2015, A1, . Location in patent: Page/Page column 49
[4] Patent: WO2007/143823, 2007, A1, . Location in patent: Page/Page column 36
  • 8
  • [ 67-56-1 ]
  • [ 5096-73-1 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: WO2014/28669, 2014, A1, . Location in patent: Paragraph 00320
  • 9
  • [ 124-41-4 ]
  • [ 6531-04-0 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: US2014/154179, 2014, A1, . Location in patent: Paragraph 0333; 0334
  • 10
  • [ 5096-73-1 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: US2014/154179, 2014, A1,
[2] Patent: WO2015/143653, 2015, A1,
[3] Patent: WO2007/143823, 2007, A1,
  • 11
  • [ 1121-79-5 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: WO2007/143823, 2007, A1,
  • 12
  • [ 37972-69-3 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: EP2316827, 2016, B1,
[2] Patent: EP3333157, 2018, A1,
  • 13
  • [ 27372-38-9 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: EP3333157, 2018, A1,
  • 14
  • [ 37972-69-3 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: EP3333157, 2018, A1,
  • 15
  • [ 328-50-7 ]
  • [ 65202-50-8 ]
Reference: [1] Patent: EP3333157, 2018, A1,
  • 16
  • [ 65202-50-8 ]
  • [ 1011487-94-7 ]
Reference: [1] Patent: WO2012/81736, 2012, A1, . Location in patent: Page/Page column 82
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 65202-50-8 ]

Chlorides

Chemical Structure| 75680-92-1

[ 75680-92-1 ]

Ethyl 6-chloro-3-pyridazinecarboxylate

Similarity: 0.96

Chemical Structure| 5096-73-1

[ 5096-73-1 ]

6-Chloropyridazine-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 372118-01-9

[ 372118-01-9 ]

Methyl 4,6-dichloropyridazine-3-carboxylate

Similarity: 0.81

Chemical Structure| 1121-79-5

[ 1121-79-5 ]

3-Chloro-6-methylpyridazine

Similarity: 0.67

Chemical Structure| 66346-83-6

[ 66346-83-6 ]

6-Chloropyridazine-3-carboxamide

Similarity: 0.66

Esters

Chemical Structure| 75680-92-1

[ 75680-92-1 ]

Ethyl 6-chloro-3-pyridazinecarboxylate

Similarity: 0.96

Chemical Structure| 372118-01-9

[ 372118-01-9 ]

Methyl 4,6-dichloropyridazine-3-carboxylate

Similarity: 0.81

Chemical Structure| 1093860-48-0

[ 1093860-48-0 ]

Methyl 6-chloropyridazine-4-carboxylate

Similarity: 0.62

Chemical Structure| 1352925-63-3

[ 1352925-63-3 ]

Ethyl 4,6-dihydroxypyridazine-3-carboxylate

Similarity: 0.59

Chemical Structure| 1193-62-0

[ 1193-62-0 ]

Methyl 1H-pyrrole-2-carboxylate

Similarity: 0.58

Related Parent Nucleus of
[ 65202-50-8 ]

Pyridazines

Chemical Structure| 75680-92-1

[ 75680-92-1 ]

Ethyl 6-chloro-3-pyridazinecarboxylate

Similarity: 0.96

Chemical Structure| 5096-73-1

[ 5096-73-1 ]

6-Chloropyridazine-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 372118-01-9

[ 372118-01-9 ]

Methyl 4,6-dichloropyridazine-3-carboxylate

Similarity: 0.81

Chemical Structure| 2164-61-6

[ 2164-61-6 ]

Pyridazine-3-carboxylic acid

Similarity: 0.72

Chemical Structure| 1121-79-5

[ 1121-79-5 ]

3-Chloro-6-methylpyridazine

Similarity: 0.67